Chapter title |
Glucocorticosteroids
|
---|---|
Chapter number | 62 |
Book title |
Pharmacology and Therapeutics of Asthma and COPD
|
Published in |
Handbook of experimental pharmacology, January 2016
|
DOI | 10.1007/164_2016_62 |
Pubmed ID | |
Book ISBNs |
978-3-31-952173-2, 978-3-31-952175-6
|
Authors |
Peter J. Barnes, Barnes, Peter J. |
Abstract |
Glucocorticosteroids are the most effective anti-inflammatory therapy for asthma but are relatively ineffective in COPD. Glucocorticoids are broad-spectrum anti-inflammatory drugs that suppress inflammation via several molecular mechanisms. Glucocorticoids suppress the multiple inflammatory genes that are activated in asthma by reversing histone acetylation of activated inflammatory genes through binding of ligand-bound glucocorticoid receptors (GR) to coactivator molecules and recruitment of histone deacetylase-2 (HDAC2) to the activated inflammatory gene transcription complex (trans-repression). At higher concentrations of glucocorticoids GR homodimers interact with DNA recognition sites to activate transcription through increased histone acetylation of anti-inflammatory genes and transcription of several genes linked to glucocorticoid side effects (trans-activation). Glucocorticoids also have post-transcriptional effects and decrease stability of some proinflammatory mRNAs. Decreased glucocorticoid responsiveness is found in patients with severe asthma and asthmatics who smoke, as well as in all patients with COPD. Several molecular mechanisms of glucocorticoid resistance have now been identified which involve phosphorylation and other post-translational modifications of GR. HDAC2 is markedly reduced in activity and expression as a result of oxidative/nitrative stress and pi3 kinase-δ inhibition, so that inflammation is resistant to the anti-inflammatory actions of glucocorticoids. Dissociated glucocorticoids and selective GR modulators which show improved trans-repression over trans-activation effects have been developed to reduce side effects, but so far it has been difficult to dissociate anti-inflammatory effects from adverse effects. In patients with glucocorticoid resistance alternative anti-inflammatory treatments are being investigated as well as drugs that may reverse the molecular mechanisms of glucocorticoid resistance. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 106 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 17 | 16% |
Student > Master | 12 | 11% |
Researcher | 9 | 8% |
Student > Bachelor | 7 | 7% |
Student > Doctoral Student | 5 | 5% |
Other | 14 | 13% |
Unknown | 42 | 40% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 19 | 18% |
Biochemistry, Genetics and Molecular Biology | 13 | 12% |
Agricultural and Biological Sciences | 9 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 6% |
Immunology and Microbiology | 4 | 4% |
Other | 8 | 8% |
Unknown | 47 | 44% |